Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NTLA compared with CRSP: revenue, margins and what each company keeps, and the suppliers and customers both name
NTLA
Intellia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
CRSP
CRISPR Therapeutics AG
Change
Mkt cap
Revenue
Revenue
vs
Compare
NTLA
Intellia Therapeutics, Inc.
vs
CRSP
CRISPR Therapeutics AG
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
NTLA
Intellia Therapeutics, Inc.
Change
11.35
▲
+2.23%
· post 11.31
Mkt cap
$1.6B
Revenue
$7M
Q3 FY26
Revenue
$68M
FY25
CRSP
CRISPR Therapeutics AG
Change
50.08
▲
+3.13%
· post 50.00
Closed
Nov 6 '26
Mkt cap
$4.9B
Revenue
$13M
Q3 FY26
Revenue
$4M
FY25
vs
Compare
Closed
Nov 6 '26
NTLA
Intellia Therapeutics, Inc.
vs
CRSP
CRISPR Therapeutics AG
11.35
▲
+2.23%
post 11.31
Price
50.08
▲
+3.13%
post 50.00
$1.6B
Mkt cap
$4.9B
Q3 FY26
$7M
Revenue
$13M
Q3 FY26
FY25
$68M
Revenue
$4M
FY25
Change
Change
NTLA
11.35
▲
+2.23%
vs
CRSP
50.08
▲
+3.13%
Closed
Nov 6 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NTLA, solid
CRSP, dashed
Supply-chain overlap
Revenue flow
NTLA: latest quarter is a loss; flow not drawable. CRSP: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NTLA
4
REGN
Regeneron Pharmaceuticals
customer
CRBU
Caribou Biosciences
supplier
—
AvenCell Therapeutics
unlisted
customer
—
SparingVision SAS
unlisted
customer
Shared
0
No shared counterparties.
Only CRSP
5
LLY
Eli Lilly
customer
VRTX
Vertex
customer
VERX
Vertex Pharmaceuticals
customer
ACET
Adicet Bio
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
1 more · CRSP chain
›